Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
In a recent webinar titled “QP release in the EU in 2022 and beyond: Your questions answered,” two clinical QP experts from Thermo Fisher Scientific discussed the expectations and responsibilities of the UK and EU QPs in ensuring supply of clinical and commercial drug products between the UK and the EU. Their observations and responses to key questions are shared in this article.